Trading status
Status
de
Prices realtime
Indizes
Germany 40
MID Germany 50
TEC Germany 30
USA 30
EUROPE 50
TEC USA 100
Shares
ETFs & FUNDS
Bonds
Crypto
Screen markets
Stock screener
Certifcate Screener
ETF Screener
Fund Screener
Bond screener
Trading ideas
risk indices
risk indices
EU Intraday
EU Long Term
US Intraday
US Longterm
Newsletter
Blog
Newsletter
Watchlist
Support
Trading
Trading Calendar
New on gettex
New listings stocks
New listings bonds
New intraday certificates
Extended trading hours
Listing on demand
Announcements
Delayed Data
Regulations
Become a Trade Participant
Cancellations
About Gettex
FAQs
Press
Partners
Committees
Career
Service & Contact
Why gettex
Experts from BNP Paribas explain.
News
2026/08/31 19:00
Teva Seeks to Boost Neuroscience Portfolio With BioXcel Asset Bid
(Zacks)
2026/08/31 12:00
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m
(PBR)
2026/08/28 12:33
BioXcel files for Chapter 11, will sell assets to Teva
(SeekingAlpha)
2026/08/14 02:30
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Misses Revenue Estimates
(Zacks)
2026/06/02 19:45
What Makes BioXcel Therapeutics (BTAI) a New Buy Stock
(Zacks)
2026/05/15 16:00
BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates
(Zacks)
2026/05/15 13:09
BioXcel Therapeutics GAAP EPS of -$0.54 misses by $0.06, revenue of $0.21M misses by $0.17M
(SeekingAlpha)
2026/05/15 13:03
BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
(GlobeNewswire EN)
2026/05/04 17:30
BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?
(Zacks)
2026/04/17 13:03
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
(GlobeNewswire EN)
2026/04/10 01:57
Did BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
(PR Newswire)
2026/04/08 13:03
BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions
(GlobeNewswire EN)
2026/04/01 13:03
BioXcel Therapeutics Announces Food & Drug Administration Acceptance of Supplemental New Drug Application for Use of IGALMI® in the At-Home Setting
(GlobeNewswire EN)
2026/03/27 12:06
BioXcel Therapeutics GAAP EPS of -$0.58 beats by $0.06, revenue of $0.26M beats by $0.11M
(SeekingAlpha)
2026/03/27 12:03
BioXcel Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results as Company Prepares for Potential IGALMI® Approval in Outpatient Setting
(GlobeNewswire EN)
2026/03/11 21:21
BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering
(GlobeNewswire EN)
2026/03/10 19:39
BioXcel Therapeutics Announces Approximately $8.0 Million Registered Direct Offering
(GlobeNewswire EN)
2026/03/06 16:54
Why Are BioXcel Therapeutics Shares Down Friday?
(Benzinga)
2025/10/13 13:03
BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation
(GlobeNewswire EN)
2025/09/18 13:48
BioXcel regains compliance with Nasdaq listing rule
(SeekingAlpha)
2025/09/10 22:00
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients
(Benzinga)
Load more news